HealthWarehouse.com, Inc. (HEWA)
Chart Events
Performance Outlook
| Previous Close | 0.1650 |
| Open | 0.1800 |
| Bid | 3.5000 x 500 |
| Ask | 4.7500 x 500 |
| Day's Range | 0.1800 - 0.1800 |
| 52 Week Range | 0.1400 - 0.3000 |
| Volume | |
| Avg. Volume | 33,237 |
| Market Cap | 9.392M |
| Beta (5Y Monthly) | 0.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0220 |
| Earnings Date | Aug 11, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for HEWA
Related Research
- HEALTHWAREHOUSE.COM INCAnalyst Report: AmerisourceBergen CorporationAmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospital networks, and healthcare providers. Along with McKesson and Cardinal Health, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Through bolt-on acquisitions, the company has expanded into international wholesale in Europe (Alliance Healthcare). AmerisourceBergen provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).RatingFair ValueEconomic MoatyesterdayMorningstar
- Business Wire
HealthWarehouse.com Reports Results for First Quarter 2022
CINCINNATI, May 12, 2022--HealthWarehouse.com, Inc. (OTC:HEWA) announced today net sales for the first quarter of 2022 totaled $4,314,980, a 13% increase over the same period in 2021, resulting from strong growth in partner services revenue and an increase in direct-to-consumer sales. The Company reported a loss from operations of $213,988 for the quarter while generating positive cash flow of $64,047, as reflected by Adjusted EBITDA (the Company’s non-GAAP internal measure).
- Business Wire
HealthWarehouse.com Reports Full Year 2021 Results
CINCINNATI, March 17, 2022--HealthWarehouse.com, Inc. said its net sales for 2021 were $16,143,906, with higher prescription sales driven by partner services revenue.
- Business Wire
HealthWarehouse.com Reports Results for Third Quarter 2021
CINCINNATI, November 15, 2021--HealthWarehouse.com, Inc. (OTCQB: HEWA) announced net sales for the third quarter of 2021 were $4,212,127, a 5% increase from the same quarter in 2020, with prescription sales increasing 13%. The Company reported a loss from operations of $181,031 for its quarter ended September 30, 2021, but positive cash flow, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $89,797 in the third quarter.
